Global Bioenergies: first success in scaling up the Isobutene process in the Leuna Demo plant
Evry (France) and Leuna (Germany), 24 April 2017 - Global Bioenergies today announces that it has succeeded in producing Isobutene by fermentation at the scale of the Leuna Demo plant (a 5,000 litre fermenter), with run length and performances exceeding those performed on the pilot plant in Pomacle (a 500 litre fermenter).
Success in this phase of the process' scale up was obtained less than five months after start-up of the fermentation unit at the Leuna Demo plant, in December 2016. This success is an important milestone on the critical path to large scale operation of the Isobutene process.
Ales Bulc, Managing Director of the German subsidiary of Global Bioenergies, says: "The direct production of gaseous Isobutene by fermentation is a novel field which we are pioneering. It was far from certain that we would be able to so quickly replicate at the scale of the demo plant the results achieved in smaller volumes."
Rick Bockrath, VP Chemical Engineering, adds: "Today, the process is still below commercial metrics and our efforts over the coming months will focus on improving productivity."
Denis Thibaut, Fermentation Manager, points out: "New strains and new protocols associated with improved performances have recently been identified in the laboratory. They will soon be transferred to the Demo plant."
The Company also announces that the purification unit has also received the approval from the TÜV, the principal certification body in Germany. After commissioning of the filling station, the Demo plant will be fully certified for operation. Delivery to partners of the first batches of Isobutene for testing is expected in June timeframe.
Marc Delcourt, CEO of Global Bioenergies, concludes: "One of our major objectives for 2017 will be to come closer to commercial performances at Leuna Demo plant. We will then have a mature process, ready to be transferred to the future commercial plants."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, operates an industrial pilot, has started operations at its demo plant in Germany, and is preparing its first full-scale plant through a joint venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Frédéric PÂQUES
Chief Operations Officer
Phone: +33 (0)1 64 98 20 50
Email: [email protected]
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/0fe3adcc-2b84-4f33-9eb1-b5dabcba8c6a


Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer
One Percent Rule Checklist For Safer Forex Trading Risk
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 



